Clinical Trial Update: US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

ExCellThera's US trial of ECT-001-CB in pediatric and young adult patients with high-risk myeloid malignancies (cord blood transplant) has completed Phase 1 and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloid Malignancies

Drugs mentioned

• ECT-001-CB

Snippet

Sponsor: ExCellThera inc. | Conditions: High Risk Myeloid Malignancies, Cord Blood Transplant | Phase 1, Phase 2 | Status: COMPLETED